Tegafur: all 197 studies that test it
Page 2 of 2. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.
- Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric JunctionCompletedNCT02564367Phase 1/2
- Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract CancerStatus unknownNCT02527824Phase 2
- Study of Oxaliplatin, Irinotecan, and S-1 in Gastric CancerCompletedNCT02527785Phase 2
- Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) CancerStatus unknownNCT02512380Phase 3
- Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic CancerCompletedNCT02459652Phase 2
- TOF Versus SOX in Metastatic Gastric CancerCompletedNCT02442362Phase 2/3
- A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract CancerCompletedNCT02425137Phase 2
- Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal CancerCompletedNCT02347904Phase 1
- A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric AdenocarcinomaCompletedNCT02301481Phase 2
- A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric CancerStatus unknownNCT02296658Phase 2
- RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).Status unknownNCT02280070Phase 2
- GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract CancerCompletedNCT02182778Phase 3
- S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic CancerCompletedNCT02131493Phase 2
- Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric CancerCompletedNCT02114359Phase 3
- A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCCStatus unknownNCT01997957Phase 4
- Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric CancerStatus unknownNCT01980407Phase 2
- S-1 in Combination With Abraxane in Treating CholangiocarcinomaCompletedNCT01963325Phase 2
- A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric CancerTerminatedNCT01946061Phase 2
- A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.CompletedNCT01929421Phase 2
- A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung CancerCompletedNCT01874678Not applicable
- Neoadjuvant ECS Versus ECF in Local Advanced Breast CancerStatus unknownNCT01849380Phase 4
- Study of S-1 in Combination With Radiotherapy in Esophageal CancerCompletedNCT01831531Phase 2
- Postoperative Chemoradiotherapy With S-1 in Gastric CancerCompletedNCT01824004Phase 2
- A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node MetastasisStatus unknownNCT01821248Phase 2
- Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract CancerCompletedNCT01815307Phase 2
- Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric CancerStatus unknownNCT01795027Phase 3
- Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic CancerCompletedNCT01781520Phase 1/2
- Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II TrialStatus unknownNCT01761461Phase 3
- A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major HepatectomyCompletedNCT01713387Phase 1
- Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal CancerTerminatedNCT01704690Phase 2/3
- Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck CancerCompletedNCT01645748Phase 2
- A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid TumorsCompletedNCT01610479Phase 1
- SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric CancerStatus unknownNCT01583361Phase 3
- Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric AdenocarcinomaStatus unknownNCT01552980Phase 2
- S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT01533324Phase 2
- Perioperative Chemotherapy for Potentially Resectable Gastric CancerCompletedNCT01516944Phase 2/3
- A Feasibility Study of Oral Adjuvant Chemotherapy With S-1CompletedNCT01459185Phase 2
- Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic CancerCompletedNCT01430052Phase 2
- Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT01429961Phase 2
- S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric CancerStatus unknownNCT01426646Phase 2
- The Study of Metastatic Pancreatic AdenocarcinomaCompletedNCT01415713Phase 1/2
- SOX as Salvage Treatment in Nasopharyngeal CarcinomaTerminatedNCT01403259Phase 2
- S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric CarcinomaCompletedNCT01364376Not applicable
- Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract CancerCompletedNCT01291615Phase 1
- A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric CancerCompletedNCT01291407Phase 1
- Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract CancerCompletedNCT01284413Phase 1/2
- Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric CancerCompletedNCT01283204Phase 2
- A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric CancerCompletedNCT01269255Phase 1
- A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal CancerCompletedNCT01269216Phase 2
- S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal CancerStatus unknownNCT01193452Phase 2
- S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal CancerCompletedNCT01175460Phase 1
- S-1 and Radiotherapy in Elderly Patients With Esophageal CancerCompletedNCT01175447Phase 1
- Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular CarcinomaCompletedNCT01131689Phase 1
- Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in ChinaCompletedNCT01110941Phase 1/2
- Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RTTerminatedNCT01106066Phase 1/2
- A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer PatientsStatus unknownNCT01100801Phase 2
- Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary CancerTerminatedNCT01096745Phase 2
- Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerStatus unknownNCT01090505Phase 2
- Study of S-1 as Second Line Treatment on Advanced Pancreatic CancersStatus unknownNCT01074996Phase 2
- Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric CancerStatus unknownNCT00980603Phase 2
- A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric CarcinomaCompletedNCT00980382Phase 1/2
- Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric CancerStatus unknownNCT00961077Phase 2
- Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOSCompletedNCT00915382Phase 3
- A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00874328Phase 1/2
- Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00805012Phase 2
- Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal CancerCompletedNCT00677443Phase 3
- Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00652561Phase 2
- Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic CancerCompletedNCT00652054Phase 2
- Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00651833Phase 2
- Second Line Chemotherapy for S-1 Refractory Advanced Gastric CancerCompletedNCT00639327Phase 2/3
- S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenTerminatedNCT00602745Phase 3
- Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric CancerStatus unknownNCT00587145Phase 2
- S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric CancerStatus unknownNCT00580359Phase 2
- Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569790Phase 2
- Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)CompletedNCT00569699Phase 2
- Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569335Phase 2
- A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal CancerCompletedNCT00531245Phase 1/2
- Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast CancerCompletedNCT00527930Phase 2
- Phase I/II Study of SOL for Untreated Metastatic Colorectal CancerStatus unknownNCT00524706Phase 1/2
- Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric CarcinomaStatus unknownNCT00515190Phase 2
- GEM vs GEM+TS-1 for Advanced Pancreatic CancerCompletedNCT00514163Phase 2
- A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric CancerCompletedNCT00512681Phase 2
- Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal CancerStatus unknownNCT00506571Phase 2
- A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal MalignancyStatus unknownNCT00506207Phase 1
- Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric CarcinomaTerminatedNCT00503321Phase 2/3
- Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic CancerCompletedNCT00498225Phase 3
- A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic CancerCompletedNCT00436423Phase 2
- A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid TumorsCompletedNCT00400023Phase 1
- Evaluating Patients With Impaired Hepatic FunctionCompletedNCT00398424Phase 1
- Evaluating Patients With Varying Degrees of Renal FunctionCompletedNCT00398307Phase 1
- S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric CancerStatus unknownNCT00343668Phase 2
- Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric CancerCompletedNCT00287768Phase 3
- Clinical Trial of Chemosensitivity TestCompletedNCT00287755Phase 2
- Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal CancerCompletedNCT00284258Phase 2/3
- Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric CancerCompletedNCT00202969Phase 3
- Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ CancerStatus unknownNCT00197431Phase 2
- Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric CancerCompletedNCT00150670Phase 3